LIPT1 and gastric adenocarcinoma: Conversely, LIPT1 expression was significantly up-regulated in some other tumors, including cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), liver hepatocellular carcinoma (LIHC) and stomach adenocarcinoma (STAD).